Journal of Clinical Oncology, Vol 5, 1221-1231, Copyright © 1987 by American Society of Clinical Oncology

ARTICLES

Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy

TW Pendergrass, JM Milstein, JR Geyer, AF Mulne, EJ Kosnik, JD Morris, RL Heideman, FB Ruymann, JT Stuntz and WA Bleyer

The development of a new multidrug chemotherapy regimen for primary brain tumors was based upon the cellular heterogeneity within individual tumors, the Goldie-Coldman and Price-Goldie-Hill hypotheses, and known agonistic effects of certain drug combinations and sequences. Eight drugs (vincristine [VCR], hydroxyurea, procarbazine, CCNU, cisplatin, cytosine arabinoside [Ara-C] high-dose methylprednisolone, and either cyclophosphamide or dacarbazine) were administered within 12 hours in an attempt to minimize myelosuppression. Courses were repeated at 2- to 4-week intervals. The regimen was devised to include lipid and water soluble drugs, polar and nonpolar agents, phase-specific and cell- cycle independent agents, and antineoplastics with different mechanisms of action. More than 330 courses of the regimen were administered to 107 children with brain tumors whose tumor had recurred or had been incompletely resected at diagnosis. Tumor response according to protocol-specified criteria and independent review was evaluable in 78% of the patients. After just two cycles of chemotherapy and within a 4- to 6-week interval, 50% had an objective tumor response including 15.5% who had a complete response (CR). Nephrotoxicity and high-frequency hearing losses were noted after three to five courses of therapy in approximately half of the patients. Transfusions with red cells or platelets and use of antibiotics for fever and neutropenia were required in 10% to 25% of patients. The regimen appears satisfactory for preradiation chemotherapy in newly diagnosed patients with residual tumor after surgery, but it must be compared with standard therapeutic approaches in prospective controlled trials before its relative value can be established.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. Frappaz, M. Schell, P. Thiesse, P. Marec-Berard, C. Mottolese, D. Perol, C. Bergeron, T. Philip, A. C. Ricci, S. Galand-Desme, et al. Preradiation chemotherapy may improve survival in pediatric diffuse intrinsic brainstem gliomas: Final results of BSG 98 prospective trial Neuro-oncol, August 1, 2008; 10(4): 599 - 607. [Abstract] [Full Text] [PDF]

				S. Partap, M. Walker, W. T. Longstreth Jr, and A. M. Spence Prolonged but reversible migraine-like episodes long after cranial irradiation Neurology, April 11, 2006; 66(7): 1105 - 1107. [Abstract] [Full Text] [PDF]

				D. A. Reardon, M. J. Egorin, J. A. Quinn, J. N. Rich Sr, I. Gururangan, J. J. Vredenburgh, A. Desjardins, S. Sathornsumetee, J. M. Provenzale, J. E. Herndon II, et al. Phase II Study of Imatinib Mesylate Plus Hydroxyurea in Adults With Recurrent Glioblastoma Multiforme J. Clin. Oncol., December 20, 2005; 23(36): 9359 - 9368. [Abstract] [Full Text] [PDF]

				V. Oyharcabal-Bourden, C. Kalifa, J.C. Gentet, D. Frappaz, C. Edan, P. Chastagner, E. Sariban, A. Pagnier, A. Babin, F. Pichon, et al. Standard-Risk Medulloblastoma Treated by Adjuvant Chemotherapy Followed by Reduced-Dose Craniospinal Radiation Therapy: A French Society of Pediatric Oncology Study J. Clin. Oncol., July 20, 2005; 23(21): 4726 - 4734. [Abstract] [Full Text] [PDF]

				M. Massimino, L. Gandola, R. Luksch, F. Spreafico, D. Riva, C. Solero, F. Giangaspero, F. Locatelli, M. Podda, F. Bozzi, et al. Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma Neuro-oncol, January 1, 2005; 7(1): 41 - 48. [Abstract] [PDF]

				I. F. Pollack, J. M. Boyett, A. J. Yates, P. C. Burger, F. H. Gilles, R. L. Davis, J. L. Finlay, and for the Children's Cancer Group The influence of central review on outcome associations in childhood malignant gliomas: Results from the CCG-945 experience Neuro-oncol, July 1, 2003; 5(3): 197 - 207. [Abstract] [PDF]

				M. T. Jennings, R. Sposto, J. M. Boyett, L. G. Vezina, E. Holmes, M. S. Berger, C. S. Bruggers, J. M. Bruner, K.-W. Chan, K. E. Dusenbery, et al. Preradiation Chemotherapy in Primary High-Risk Brainstem Tumors: Phase II Study CCG-9941 of the Children's Cancer Group J. Clin. Oncol., August 15, 2002; 20(16): 3431 - 3437. [Abstract] [Full Text] [PDF]

				I. F. Pollack, S. D. Finkelstein, J. Burnham, E. J. Holmes, R. L. Hamilton, A. J. Yates, J. L. Finlay, and R. Sposto Age and TP53 Mutation Frequency in Childhood Malignant Gliomas: Results in a Multi-institutional Cohort Cancer Res., October 1, 2001; 61(20): 7404 - 7407. [Abstract] [Full Text] [PDF]

				R. J. Packer, P. Cogen, G. Vezina, and L. B. Rorke Medulloblastoma: Clinical and biologic aspects Neuro-oncol, July 1, 1999; 1(3): 232 - 250. [Abstract] [PDF]

				P. M. Zeltzer, J. M. Boyett, J. L. Finlay, A. L. Albright, L. B. Rorke, J. M. Milstein, J. C. Allen, K. R. Stevens, P. Stanley, H. Li, et al. Metastasis Stage, Adjuvant Treatment, and Residual Tumor Are Prognostic Factors for Medulloblastoma in Children: Conclusions From the Children's Cancer Group 921 Randomized Phase III Study J. Clin. Oncol., March 1, 1999; 17(3): 832 - 832. [Abstract] [Full Text] [PDF]

				M. C. Chamberlain Recurrent Supratentorial Malignant Gliomas in Children: Long-term Salvage Therapy With Oral Etoposide Arch Neurol, May 1, 1997; 54(5): 554 - 558. [Abstract] [PDF]

				R. J. Packer and J. L. Finlay Chemotherapy for Childhood Medulloblastoma and Primitive Neuroectodermal Tumors Oncologist, December 1, 1996; 1(6): 381 - 393. [Abstract] [Full Text] [PDF]

				I. F. Pollack Brain Tumors in Children N. Engl. J. Med., December 1, 1994; 331(22): 1500 - 1507. [Full Text]

				B. L. Maria, K. Rehder, T. A. Eskin, L. M. Hamed, E. B. Fennell, R. G. Quisling, J. P. Mickle, R. B. Marcus Jr, W. E. Drane, N. P. Mendenhall, et al. Topical Review Article: Brainstem Glioma: I. Pathology, Clinical Features, and Therapy J Child Neurol, April 1, 1993; 8(2): 112 - 128. [Abstract] [PDF]

				F. H. Tomlinson, B. W. Scheithauer, F. B. Meyer, W. A. Smithson, E. G. Shaw, G. M. Miller, and R. V. Groover Topical Review Article: Medulloblastoma: I. Clinical, Diagnostic, and Therapeutic Overview J Child Neurol, April 1, 1992; 7(2): 142 - 155. [Abstract] [PDF]